BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 10907630)

  • 1. Raloxifene remains an option.
    MacIver DW
    Can Fam Physician; 2002 Apr; 48():679; author reply 679-80. PubMed ID: 12046354
    [No Abstract]   [Full Text] [Related]  

  • 2. Raloxifene reduces risk of vertebral fractures [corrected] in postmenopausal women regardless of prior hormone therapy.
    Johnell O; Cauley JA; Kulkarni PM; Wong M; Stock JL
    J Fam Pract; 2004 Oct; 53(10):789-96. PubMed ID: 15469774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does raloxifene reduce risk of vertebral fractures? Is this another, brighter way to treat osteoporosis?
    Hathirat S; Evans MF
    Can Fam Physician; 2001 Oct; 47():1982-4. PubMed ID: 11723592
    [No Abstract]   [Full Text] [Related]  

  • 4. Reduction of vertebral fracture risk with raloxifene.
    Bashore R
    J Fam Pract; 1999 Nov; 48(11):911-2. PubMed ID: 10907630
    [No Abstract]   [Full Text] [Related]  

  • 5. [Relationship between changes in biochemical markers of bone turnover and prediction value of fracture risk].
    Cyaki O
    Clin Calcium; 2004 Oct; 14(10):39-46. PubMed ID: 15577130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evidence of raloxifene on postmenopausal osteoporosis].
    Okano H
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():374-80. PubMed ID: 18161135
    [No Abstract]   [Full Text] [Related]  

  • 7. [Which is the better choice, estrogen or SERMs in postmenopausal women?].
    Shintani M
    Clin Calcium; 2004 Oct; 14(10):105-10. PubMed ID: 15577140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of SERMs on bone health. Efficacy of SERM for incidence of fractures in osteoporotic patients with lifestyle-related diseases].
    Sakai A; Nakamura T
    Clin Calcium; 2010 Mar; 20(3):322-9. PubMed ID: 20190361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [MORE study(raloxifene)].
    Itabashi A
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():442-9. PubMed ID: 15035168
    [No Abstract]   [Full Text] [Related]  

  • 10. Who will benefit from treatment with selective estrogen receptor modulators (SERMs)?
    Sambrook P
    Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):975-81. PubMed ID: 16301191
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.